🟢 Immunic is trading 7.2% up in pre-market amid broader biotech strength

Immunic is trading $11.62, up 7.2%, as biotechnology shares are broadly stronger pre-market; the move appears primarily sector-driven.

• The price compares with the September 22 close of $10.84.
• No new company-specific announcement was identified for September 23, 2026.
• Immunic’s latest listed release remains its September 2 announcement about the September 9 multiple-sclerosis R&D Day.